KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Humana (HUM) EBT (2016 - 2025)

Humana (HUM) has disclosed EBT for 16 consecutive years, with -$1.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, EBT changed N/A to -$1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a N/A change, with the full-year FY2025 number at $1.6 billion, down 9.65% from a year prior.
  • EBT was -$1.0 billion for Q4 2025 at Humana, down from $400.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.7 billion in Q1 2025 to a low of -$1.0 billion in Q4 2025.
  • A 4-year average of $847.8 million and a median of $1.1 billion in 2023 define the central range for EBT.
  • Biggest YoY gain for EBT was 86.9% in 2021; the steepest drop was 71.46% in 2021.
  • Humana's EBT stood at -$60.0 million in 2021, then fell by 18.33% to -$71.0 million in 2022, then surged by 1646.48% to $1.1 billion in 2023, then plummeted by 192.08% to -$1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's EBT are -$1.0 billion (Q4 2025), $400.0 million (Q3 2025), and $741.0 million (Q2 2025).